| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.008 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |